| Model Number |
S-50-030-120-P6 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Stenosis (2263)
|
| Date of Event |
07/03/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Dates of event: estimated dates.The device was not returned for analysis as the stent remains in the patient.The lot history record (lhr) for this product could not be reviewed and a similar complaint query could not be performed because the product was not returned for evaluation and the lot number was not reported.The reported patient effect of restenosis is listed in the supera instructions for use as a known potential patient effect.Based on the reported information, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The surgical procedure was related to case circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature attachment: pathology and multimodality imaging of acute and chronic femoral stenting in humans.The other supera referenced as case ten in the article is being filed under a separate medwatch report number.
|
| |
|
Event or Problem Description
|
|
It was reported that the 5.0x30 mm supera stent was implanted in the superficial femoral artery to treat the patient with intermittent claudication.300 days after the implant procedure, the patient had in-stent restenosis.This was a patient referenced as case six in the article titled, pathology and multimodality imaging of acute and chronic femoral stenting in humans.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.
|
| |
|
Search Alerts/Recalls
|